What are the implications of a low Anti-Mullerian Hormone (AMH) level?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Low anti-Müllerian hormone (AMH) levels are associated with a significantly increased risk of miscarriage, particularly in women with AMH levels below 0.7 ng/ml, with an odds ratio of 1.63 [1.05–2.53] compared to those with higher AMH levels 1.

Implications of Low AMH Levels

Low AMH levels indicate diminished ovarian reserve, which can affect fertility and increase the risk of miscarriage. The risk of miscarriage is higher in women with low AMH levels, especially those under 35 years old, with an odds ratio of 1.24 [1.06–1.44] 1.

Fertility Treatment Options

If you have low AMH and are trying to conceive, it is essential to consult with a reproductive endocrinologist promptly, as fertility declines with age. Treatment options may include:

  • Ovarian stimulation with medications like clomiphene citrate or injectable gonadotropins, often combined with intrauterine insemination or in vitro fertilization
  • Supplements like DHEA, CoQ10, or vitamin D, although evidence for these is limited 1

Lifestyle Modifications

Lifestyle modifications, such as:

  • Maintaining a healthy weight
  • Avoiding smoking
  • Reducing alcohol consumption
  • Managing stress may help optimize fertility.

Monitoring Reproductive Health

Regular monitoring of reproductive health is crucial if you have low AMH and plan to become pregnant in the future, as very low AMH levels may indicate early menopause or primary ovarian insufficiency 1.

From the Research

Implications of Low Anti-Mullerian Hormone (AMH) Levels

  • Low AMH levels have been associated with poor ovarian reserve, poor ovarian response to stimulation, and decreased success rates with fertility treatments 2, 3, 4
  • Women with low AMH levels may have a shorter reproductive window and may be considered 'sub-fertile' 2, 3
  • Low AMH levels have been linked to recurrent miscarriages, although the exact mechanism is not fully understood 2, 5
  • AMH levels do not reflect oocyte health or chances for conception, but rather the quantity of remaining oocytes 3, 6
  • A cut-off value of serum AMH level ≤1 ng/ml may predict poor ovarian reserve, poor ovarian response to stimulation, and IVF outcomes 4

Factors Influencing AMH Levels

  • Age is the strongest driver in determining success rates with fertility treatments, and AMH levels decline with age 3, 4
  • Body mass index (BMI) has an inverse correlation with AMH levels, but this does not reflect ovarian response 3
  • Certain medical conditions, such as multiple sclerosis, may be associated with decreased AMH levels 5
  • Hormonal contraceptive use and hypogonadotropic hypogonadism may lower AMH levels without being a true reflection of ovarian reserve 3

Clinical Implications

  • Serum AMH levels should be offered to all patients as part of a recurrent miscarriage work-up to allow for realistic counseling and possible referral for assisted reproductive technologies (ART) 2
  • AMH levels can be used to estimate expected response to ovarian stimulation and to predict IVF outcomes, but should not be used to withhold treatment 3, 4
  • Further research is needed to establish how decreased AMH levels contribute to recurrent miscarriages and to determine the optimal cut-off value for predicting poor ovarian reserve and IVF outcomes 2, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Anti-Müllerian hormone levels in recurrent embryonic miscarriage patients are frequently abnormal, and may affect pregnancy outcomes.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2019

Research

Evaluation of Female Fertility-AMH and Ovarian Reserve Testing.

The Journal of clinical endocrinology and metabolism, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.